June 24, 2025

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring the 99.81% Potential Upside

Immunocore Holdings plc (NASDAQ: IMCR), a United Kingdom-based biotechnology company, is making waves in the healthcare sector, drawing significant attention from investors with its promising pipeline and an impressive potential..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Understanding the Healthcare Innovator’s Growth Potential

In the rapidly evolving landscape of healthcare technology, Pulse Biosciences, Inc. (NASDAQ: PLSE) stands out as a pioneering force with its innovative bioelectric medicine solutions. With a focus on the..

CONMED Corporation (CNMD) Stock Analysis: Evaluating a 28.89% Potential Upside for Investors

CONMED Corporation (NYSE: CNMD), a prominent player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a potential upside of 28.89%. This figure is derived..

Vericel Corporation (VCEL) Stock Analysis: Unpacking a 42% Potential Upside

Investors eyeing the biotechnology sector may find Vericel Corporation (NASDAQ: VCEL) an intriguing prospect, especially given its promising 42.05% potential upside. This U.S.-based healthcare company, with a market capitalization of..

Astrana Health Inc. (ASTH) Stock Analysis: A Healthcare Contender with 91% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is attracting considerable attention from investors due to its significant growth potential. With a market capitalization of $1.16..

Pacira BioSciences (PCRX) Stock Analysis: Exploring a 22.88% Upside in the Non-Opioid Pain Management Sector

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands at the forefront of the healthcare sector, particularly within the specialty drug manufacturing industry. With a market capitalization of $1.15 billion, this Tampa-based company..

MannKind Corporation (MNKD) Stock Analysis: Unlocking a Potential 148% Upside in the Biotech Industry

MannKind Corporation (NASDAQ: MNKD), a biopharmaceutical company focused on innovative therapeutic solutions for endocrine and orphan lung diseases, is capturing investor attention within the healthcare sector. With a notable potential..

Adaptive Biotechnologies (ADPT) Stock Analysis: A Promising Biotech with 12.28% Upside Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is drawing considerable attention from investors, particularly due to its potential upside of 12.28%, as indicated by analysts. Operating in the highly dynamic biotechnology sector,..

Harmony Biosciences Holdings, Inc. (HRMY) Stock Analysis: A Promising 61% Potential Upside for Investors

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotech sector with its promising therapies for rare and neurological diseases. This commercial-stage pharmaceutical company, headquartered in Plymouth Meeting,..

Envista Holdings Corp (NVST) Stock Analysis: Navigating Challenges with Strategic Positioning in the Dental Market

Envista Holdings Corporation (NYSE: NVST) stands at a crossroads in the healthcare sector, particularly within the medical instruments and supplies industry. With a current market capitalization of $3.2 billion, the..

BGM Group Ltd. (BGM): Stock Analysis Reveals Challenges Amid Revenue Decline in Healthcare Sector

BGM Group Ltd. (BGM), a player in the Healthcare sector, specifically within the Drug Manufacturers – Specialty & Generic industry in China, has caught the attention of investors with its..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 34.68% Potential Upside in Healthcare Savings

GoodRx Holdings, Inc. (NASDAQ: GDRX) has carved a niche in the healthcare sector by providing a vital service: enabling consumers to save on prescription drug purchases through an innovative price..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 30.87% Potential Upside in the Healthcare Robotics Market

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) stands as a cutting-edge leader in the medical devices sector, specifically within the realm of surgical robotics. Headquartered in San Jose, California, the company has..

89bio, Inc. (ETNB) Stock Analysis: Eyeing a 194.55% Upside Potential

For investors with an appetite for high-risk, high-reward opportunities, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing prospect within the biotechnology sector. Headquartered in San Francisco, this clinical-stage biopharmaceutical company is..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Unpacking the 25% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the healthcare sector with a unique focus on developing, manufacturing, and marketing medical devices for vascular surgery. With a market capitalization of..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Potential 177% Upside in the Biotech Sector

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is making waves in the biotechnology sector with its focus on rare diseases. This Princeton, New Jersey-based company is attracting significant attention from investors, particularly..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a 138% Potential Upside Amidst Innovative Vaccine Developments

Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company based in Emeryville, California, presents a riveting investment opportunity in the healthcare sector. With a market capitalization of $1.17 billion, Dynavax specializes..

Arcellx, Inc. (ACLX) Stock Analysis: Biotechnology Innovator with a Robust 74.68% Potential Upside

Arcellx, Inc. (NASDAQ: ACLX) is capturing attention with its ambitious strides in the biotechnology sector, particularly in the field of cancer immunotherapy. Specializing in developing innovative treatment options for cancers..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech Contender with a 29% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is capturing investor attention with its promising pipeline in the biotechnology sector, particularly in the realm of peptide therapeutics for hematology, blood disorders, inflammatory, and..

Neogen Corporation (NEOG) Stock Analysis: Exploring an 88.68% Potential Upside

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector’s Diagnostics & Research industry, has recently caught the attention of investors, with an exciting 88.68% potential upside based on..

Search

Funds

June 24, 2025

Search

Funds

June 24, 2025

FTSE 100

Funds